The title of the study, as presented in the provided document, is: **Sequenced Hybrid Electromechanically Assisted and Conventional Gait Training for Concurrent Optimization of Weight Management, Blood Pressure Regulation, and Functional Mobility in Chronic Stroke Survivors: A Multicenter Randomized Controlled Trial**

Research Project: Sequenced Hybrid Electromechanically Assisted and Conventional Gait Training for Concurrent Optimization of Weight Management, Blood Pressure Regulation, and Functional Mobility in Chronic Stroke Survivors Overview and Purpose My research project is a multicenter, assessor-blinded, randomized controlled trial focused on advancing rehabilitation strategies for chronic stroke survivors. Specifically, it investigates the effectiveness of a novel sequenced hybrid gait training protocol that combines electromechanically assisted gait training (EAGT, using robotic devices like exoskeletons or end-effector systems) in the initial phase, followed by conventional overground gait training (CGT). The primary purpose is to determine whether this phased hybrid approach yields superior concurrent improvements in three key areas compared to EAGT alone or CGT alone: Cardiometabolic health — particularly weight management and blood pressure regulation, in a high-risk population of overweight/obese individuals with hypertension. Functional mobility — including gait speed, endurance, balance, and overall independence in daily activities. Chronic stroke survivors frequently experience persistent gait impairments, leading to sedentary lifestyles, obesity, hypertension, and increased risk of recurrent cardiovascular events. While EAGT provides high-intensity, repetitive practice to promote neuroplasticity and aerobic capacity, CGT enhances real-world functional transfer and ecological validity. However, monotherapy with either approach has limitations: EAGT may lack task variability for long-term transfer, while CGT often achieves lower training intensity due to fatigue or safety concerns. This trial addresses a critical gap by testing whether sequencing EAGT (to build a strong foundation of repetitive, high-volume stepping and metabolic conditioning) followed by CGT (to integrate gains into functional, overground performance) creates synergistic benefits. The hypothesis is that this hybrid sequencing optimizes energy expenditure and vascular adaptations early on, while promoting sustained real-life mobility and adherence—ultimately reducing recurrence risks and improving quality of life in this vulnerable group. Study Design and Methods The trial was conducted across five specialized neurorehabilitation centers in Pakistan (including Aga Khan University Hospital in Karachi, Shaukat Khanum Memorial Cancer Hospital & Research Centre in Lahore, Pakistan Institute of Medical Sciences in Islamabad, Liaquat National Hospital in Karachi, and Saidu Group of Teaching Hospital in Swat) from March 2022 to September 2024. Participants — 140 chronic stroke survivors (aged 45–78 years, >6 months post-stroke, BMI ≥25 kg/m², diagnosed hypertension, able to walk with minimal assistance). Randomization — Stratified 1:1:1 allocation to three groups: Hybrid (n=48), EAGT-only (n=46), CGT-only (n=46). Intervention — 12 weeks (30 sessions, 45–60 minutes each): Hybrid: Weeks 1–6 EAGT (high-repetition robotic-assisted stepping with progressive parameters); Weeks 7–12 CGT (overground functional tasks like obstacle navigation and stair climbing). EAGT-only: 12 weeks of robotic training. CGT-only: 12 weeks of conventional overground training. Outcomes — Assessed at baseline, 6 weeks, 12 weeks, and 3-month follow-up. Primary: Changes in body weight and systolic/diastolic blood pressure. Secondary: Gait speed (10-meter walk test), endurance (6-minute walk test), balance (Berg Balance Scale), and daily function (Barthel Index). Rigorous methods included blinded assessors, intent-to-treat analysis, and linear mixed-effects modeling to account for repeated measures and clustering. Key Findings and Expected Outcomes The sequenced hybrid protocol demonstrated clear superiority in cardiometabolic outcomes: Greater weight loss (−4.3 kg vs. −2.9 kg in EAGT-only and −2.2 kg in CGT-only). Larger systolic blood pressure reduction (−13.1 mmHg vs. −8.4 mmHg and −7.5 mmHg, respectively). Gait and functional improvements were comparable across groups at 12 weeks, but the hybrid group showed better retention at follow-up, particularly in walking endurance. Subgroup analyses indicated even stronger benefits in participants with higher baseline obesity. These results suggest that the initial intensive EAGT phase maximizes aerobic loading and energy expenditure, preconditioning metabolic adaptations, while the subsequent CGT phase facilitates translation to functional activities and long-term adherence. Overall, the hybrid approach addresses interconnected neuromotor and cardiometabolic challenges more effectively than monotherapy. Broader Implications and Future Directions This project represents an innovative, multifaceted rehabilitation paradigm that could inform clinical guidelines, optimize resource use (e.g., limiting robotic sessions to an initial phase), and enhance secondary prevention of recurrent strokes. Expected long-term outcomes include reduced healthcare burden, improved independence, and better quality of life for chronic stroke survivors with comorbidities. Future work could incorporate personalized elements (e.g., wearable sensors), dietary integration, or longer follow-ups to assess impacts on recurrence rates. This trial provides high-quality evidence for shifting toward integrated, sequenced protocols in stroke rehabilitation.